National Regenerative Medicine and Cell Therapy Center of Excellence.
Regenerative Medicine
Cell therapy, cGMP biomanufacturing, cell banking, and clinical-trial capability.
National Regenerative Medicine and Cell Therapy Center of Excellence.
Section Navigation
Tygan University Hospitals
Regenerative Medicine
Cell therapy, cGMP biomanufacturing, cell banking, and clinical-trial capability.
South African cGMP biomanufacturing and cell-banking hub with backup/disaster-recovery capability.
Provincial clinical trial and approved-care nodes, training institute, QA/QC, GMP, GCP, pharmacovigilance, consent systems, and adverse-event reporting.
Verify all Stemedica corporate, IP, clinical, manufacturing, cGMP, safety, trial, product, commercial, and territory-rights claims.
Governance
Advanced therapy, costing, and partner claims require evidence before investor release.
Gene therapy is treated as a Tygan-owned or Tygan-controlled patent platform from project start. Medical pathways remain subject to clinical governance, SAHPRA, ethics, POPIA, patient consent, scientific validation, and independent legal review.